期刊
JOURNAL OF CLINICAL NEUROSCIENCE
卷 17, 期 1, 页码 92-95出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.jocn.2009.03.039
关键词
Adenovirus; Focal ischemia; Hypoxia-inducible factor-1 alpha; Neural stem cell; Transplantation
We explored the possibility that hypoxia-inducible factor-1 alpha (HIF-1 alpha) might contribute to the therapeutic effect of neural stem cell (NSC) transplantation in cerebral ischemia. The relative efficacy of modified NSC to promote behavioral recovery was investigated in a rat model of stroke induced by a transient middle cerebral artery occlusion (MCAO). A recombinant adenovirus (Ad-HIF-1 alpha) was engineered to express HIF-1 alpha. Control NSC infected with control adenovirus (NSC-Ad), recombinant adenovirus Ad-HIF-1 alpha, or NSC infected by Ad-HIF-1 alpha (NSC-Ad-HIF-1 alpha), were used for intraventricular transplantion into rat brain 24 hours after MCAO. Neurological deficits were assessed over 4 weeks using the modified neurological severity scale (NSS) score. Long-term in vivo expression of HIF-1 alpha was demonstrated by Western blotting and immunocytochemistry, and derivatives of nestin-positive transplanted cells contributed to both neuronal (neurofilament-positive) and astroglial (glial fibrillary acidic protein-positive) lineages. All animals showed functional improvement. Improvement was accelerated in animals receiving either NSC-Ad or Ad-HIF-1 alpha, while improvement at all times between 7 days and 28 days post MCAO was significantly greater in animals transplanted with NSC-Ad-HIF-1 alpha than for other treated animals. NSC-Ad-HIF-1 alpha cells also increased the number of factor VIII-positive cells in the region of ischemic injury, indicating that HIF-1 alpha expression can promote angiogenesis. Gene-modified NSC expressing HIF-1 alpha have therapeutic potential in ischemic stroke. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据